Cognitive Behavioral Therapy for Social Anxiety Disorder
(I-FOCUS Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to understand why some individuals respond fully to cognitive behavioral therapy and others do not, based on multiple sources of data such as neural, neurocognitive, clinical, and self-report data.
Will I have to stop taking my current medications?
The trial requires that participants stop taking psychotropic medications, except for antidepressants, which must be taken at a stable dose for at least 3 months before starting the study.
What data supports the effectiveness of this treatment for social anxiety disorder?
Research shows that cognitive-behavioral therapy (CBT) is effective for treating social anxiety disorder, with strategies like cognitive restructuring and exposure leading to both immediate and long-term improvements. Mindfulness-based stress reduction (MBSR) is also recognized as an evidence-based treatment for social anxiety disorder.12345
Is Cognitive Behavioral Therapy (CBT) safe for humans?
How does Cognitive Behavioral Therapy differ from other treatments for social anxiety disorder?
Cognitive Behavioral Therapy (CBT) is unique because it focuses on changing negative thought patterns and behaviors through techniques like exposure therapy and social skills training, which can lead to long-term improvement. Unlike medication, CBT addresses the root causes of social anxiety and can be delivered in various formats, including individual, group, and even internet-based sessions, making it accessible and adaptable.310111213
Research Team
Angela Fang, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for individuals with conditions like Body Dysmorphic Disorder, Social Anxiety Disorder, or Generalized Anxiety Disorder. It aims to understand why Cognitive Behavioral Therapy (CBT) works well for some but not others.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment
Baseline assessments including neuroimaging scans, clinical interviews, and self-report assessments
Treatment
Participants receive 12 weekly sessions of individual cognitive behavioral therapy and complete 4 fMRI scans
Post-treatment
Post-treatment assessments including neuroimaging scans and clinical interviews
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Cognitive Behavioral Therapy
Cognitive Behavioral Therapy is already approved in European Union, United States, Canada for the following indications:
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Substance use disorders
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator